185 results on '"Stransky, Elke"'
Search Results
2. Evaluation of the methoxy-X04 derivative BSC4090 for diagnosis of prodromal and early Alzheimer’s disease from bioptic olfactory mucosa
3. LeProT1, a Transporter for Proline, Glycine Betaine, and γ-Amino Butyric Acid in Tomato Pollen
4. Cognitive impairment in Glucocerebrosidase (GBA)‐associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles
5. Characteristics of serum neurofilament light chain as a biomarker in hereditary spastic paraplegia type 4
6. Effects of exergaming on hippocampal volume and brain‐derived neurotrophic factor levels in Parkinson’s disease
7. Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer’s disease
8. Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Aβ 1–42 ratios in CSF in patients with mild Alzheimer’s disease dementia
9. Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer’s disease
10. Differential Expression of Egr1 and Activation of Microglia Following Irradiation in the Rat Brain
11. Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants
12. BDNF serum and CSF concentrations in Alzheimer’s disease, normal pressure hydrocephalus and healthy controls
13. Altered lymphocyte distribution in Alzheimer’s disease
14. Effects of exergaming on hippocampal volume and brain‐derived neurotrophic factor levels in Parkinson's disease.
15. CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories
16. LeProt1, a transporter for proline, glycine betaine, and [gamma]-amino butyric acid in tomato pollen
17. Decline of immune responsiveness: A pathogenetic factor in Alzheimer’s disease?
18. Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha‐synuclein profile
19. Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches
20. Evaluation of the methoxy-X04 derivative BSC4090 for diagnosis of prodromal and early Alzheimer’s disease from bioptic olfactory mucosa
21. Parkinson’s disease: evolution of cognitive impairment and CSF Aβ1–42 profiles in a prospective longitudinal study
22. Neurofilament light chain levels in cerebrospinal fluid do not discriminate between patients with prion disease and mimics
23. Parkinson's disease: evolution of cognitive impairment and CSF Aβ1-42 profiles in a prospective longitudinal study.
24. Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease
25. Parkinson’s disease: evolution of cognitive impairment and CSF Aβ1–42profiles in a prospective longitudinal study
26. Alpha-Synuclein Levels in Blood Plasma Decline with Healthy Aging
27. Increased cerebrospinal fluid calpain activity and microparticle levels in Alzheimer's disease
28. P2-104: INCREASED CEREBROSPINAL FLUID CALPAIN ACTIVITY IN ALZHEIMER'S DISEASE
29. P1–224: Increased myeloperoxidase (MPO) plasma levels in patients with Alzheimer's disease
30. Immune Profiling in Blood Identifies sTNF-R1 Performing Comparably Well as Biomarker Panels for Classification of Alzheimer's Disease Patients
31. Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease
32. Autoantibody reactivity in serum of patients with major depression, schizophrenia and healthy controls
33. P1-028: Disequilibrium of APOE levels between serum and cerebrospinal fluid in Alzheimer's patients
34. Elevated Angiopoietin-1 Serum Levels in Patients with Alzheimer’s Disease
35. Stem Cell Factor Plasma Levels are Decreased in Alzheimer's Disease Patients with Fast Cognitive Decline after One-Year Follow-Up Period: The Pythia-Study
36. P1-095: Stem cell factor plasma levels predict cognitive decline in Alzheimer's disease patients
37. Adipocytokines and CD34+ Progenitor Cells in Alzheimer's Disease
38. Identification of a blood-based biomarker panel for classification of Alzheimer's disease
39. Decreased α-Synuclein Serum Levels in Patients with Lewy Body Dementia Compared to Alzheimer’s Disease Patients and Control Subjects
40. Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients
41. Exercise-induced normalization of decreased BDNF serum concentration in elderly women with remitted major depression
42. No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases
43. Increase of SCF plasma concentration during donepezil treatment of patients with early Alzheimer's disease
44. P2-196: Decreased G-CSF plasma levels in patients with early Alzheimer's disease - contribution to a deficient hematopoietic brain support?
45. Decreased Plasma Levels of Granulocyte-Colony Stimulating Factor (G-CSF) in Patients with Early Alzheimer's Disease
46. Increase of BDNF Serum Concentration in Lithium Treated Patients with Early Alzheimer's Disease
47. Decreased Plasma and Cerebrospinal Fluid Levels of Stem Cell Factor in Patients with Early Alzheimer's Disease
48. Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Aβ 1–42 ratios in CSF in patients with mild Alzheimer’s disease dementia
49. P1‐358: A novel, highly sensitive and specific enyzme‐linked immunosorbent assay (ELISA) for the measurement of total human alpha‐synuclein in plasma and cerebrospinal fluid
50. P1-456: Inverse association between amyloid-beta 1-42 and SDF-1 plasma levels in healthy older adults
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.